Coya Therapeutics (COYA) EBT Margin (2023 - 2026)
Coya Therapeutics (COYA) reported EBT Margin of 2869.63% for Q1 2026, down 3628.0% on a YoY basis from 81.34% in Q1 2025, and down 1226.31% sequentially from 216.36% in Q4 2025.
Coya Therapeutics (COYA) EBT Margin (2023 - 2026) Analysis & Trends
Coya Therapeutics (COYA) has 4 years of EBT Margin data on file, last reported at 2869.63% in Q1 2026.
- For the quarter ending Q1 2026, EBT Margin fell 3628.0% year-over-year to 2869.63%; the trailing twelve-month figure through Mar 2026 stood at 336.71% (up 49833.0% YoY), and the FY2025 full-year result was 266.81%, up 17213.0% from the prior year.
- EBT Margin fell to 2869.63% in Q1 2026, from 216.36% in the prior quarter.
- In the past five years, EBT Margin ranged from a high of 63.48% in Q4 2023 to a low of 625479.97% in Q4 2024.
- A 4-year average of 71043.53% and a median of 2833.35% in 2025 frame the typical range for EBT Margin.
- Across the five-year window, EBT Margin slumped 62541649 bps in 2024 and surged 62526361 bps in 2025, its largest moves.
- Tracing COYA's EBT Margin over 4 years: stood at 63.48% in 2023, then sank by 985280 bps to 625479.97% in 2024, then jumped by 100 bps to 216.36% in 2025, then plunged by 1226 bps to 2869.63% in 2026.
- Business Quant data shows COYA's EBT Margin at 2869.63% in Q1 2026, 216.36% in Q4 2025, and 136.4% in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBT Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 66,621.14 Bn | 66,620.85 Bn | - | - |
| 2 | Nanobiotix | 1,915.18 Bn | 1,915.11 Bn | - | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | - |
| 4 | BeOne Medicines | 471.27 Bn | 466.48 Bn | 1.35 Bn | 17.13% |
| 5 | Vertex Pharmaceuticals | 121.81 Bn | 114.57 Bn | 2.59 Bn | 41.95% |
| 6 | Regeneron Pharmaceuticals | 69.58 Bn | 60.82 Bn | 3.31 Bn | 23.05% |
| 7 | Belite Bio | 62.72 Bn | 62.72 Bn | - | - |
| 8 | Argenx Se | 55.51 Bn | 50.33 Bn | 1.41 Bn | 34.77% |
| 9 | Revolution Medicines | 37.35 Bn | 37.35 Bn | - | - |
| 10 | Coya Therapeutics | 97.14 Mn | 46.42 Mn | - | -2,869.63% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -2,869.63% |
| Dec 31, 2025 | -216.36% |
| Sep 30, 2025 | -136.40% |
| Jun 30, 2025 | -3,725.17% |
| Mar 31, 2025 | -2,833.35% |
| Dec 31, 2024 | -625,479.97% |
| Jun 30, 2024 | -84.42% |
| Mar 31, 2024 | -3,982.96% |
| Dec 31, 2023 | -63.48% |